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Clinical InvestigationsImaging and Diagnostic TestingDiagnostic performance of non–contrast-enhanced
whole-heart magnetic resonance coronary
angiography in combination with adenosine stress
perfusion cardiac magnetic resonance imaging
Tobias Heer, MD, Stephanie Reiter, MD, Berthold Höfling, MD, and Günter Pilz, MD Hausham, GermanyBackground We sought to evaluate the diagnostic performance of 1.5-T non-contrast enhanced whole-heart magnetic
resonance coronary angiography (MRCA) alone and in combination with adenosine stress cardiac magnetic resonance
imaging (CMR-Perf). MRCA has been proposed to allow for detection of coronary artery disease (CAD). Yet, recent studies
failed to show an incremental value of MRCA when added to CMR-Perf.
Methods Non-Gadolinium 1.5-T contrast-enhanced, electrocardiogram-triggered, navigator-gated free-breathing
MRCA was performed in 144 patients (pts) with suspected or known CAD. Accuracy of MRCA in detecting CAD
was evaluated using X-ray coronary angiography as the reference. A novel algorithm was used to combine the results of MRCA
and CMR-Perf.
Results MRCA was diagnostic in 96/144 pts (67%) with regular breathing (mean age 62.5 ± 13); 77% of all coronary
segments (939/1226) and 92% of segments suitable for percutaneous coronary intervention (792/866) were assessable. In
59 pts a novel algorithm to combine MRCA and CMR-Perf was performed with high diagnostic performance: accuracy,
sensitivity, specificity, negative and positive predictive values were 91.5% (54/59; 95% CI, 84%-99%), 95.7% (22/23; 77-
100), 88.9% (32/36; 74-96), 84.6% (22/26; 71-99), and 97.0% (32/33; 91-100). Compared to the combined use of
CMR-Perf and late gadolinium enhancement, specificity with the novel algorithm significantly increased (P = .008).
Conclusion MRCA has a high assessability in segments suitable for percutaneous coronary intervention in pts
with regular breathing. The combined use of MRCA and CMR-Perf improved specificity for the detection of significant CAD.
(Am Heart J 2013;166:999-1009.)By 2030, almost 23.6 million people will die from
cardiovascular diseases, more than 50% of them due to
coronary artery disease (CAD).1 In addition to preven-
tion, unchanging efforts have been undertaken to screen
for obstructive CAD. Recently, in a large US registry only
one third of patients who underwent elective invasive
cardiac angiography (XA) had obstructive lesions.2 In therom the AgathariedAcademic TeachingHospital, University ofMunich,Hausham,Germany.
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Olast decades there have been many improvements in non-
invasive tests to decrease superfluous XA.
Cardiac magnetic resonance imaging (CMR) has a high
diagnostic power to comprehensively assess cardiac
function, myocardial viability and perfusion imaging in
one examination.3-6 This diagnostic approach is increas-
ingly used in clinical routine7 and has been shown to be
cost-effective.8 The direct visualization of the coronary
arteries with magnetic resonance coronary angiography
(MRCA) has been improved in the last decade,9-12 but at
present coronary computed tomographic angiography
(CCTA) is considered the preferred non-invasive diagnos-
tic tool to visualize coronary arteries.13,14 Yet, CCTA has
the disadvantages of radiation exposure and the use of
iodinated contrast.
The aim of the present prospective single center study
was to evaluate the diagnostic performance of a
commercially available whole heart 3D navigator gated
multislab steady-state free precession sequence for MRCA
and to test the incremental diagnostic value of a new
Figure 1
Planning of MRCA—planning the 3D volume and the navigator at the dome of the right hemidiaphragm (white arrow). The images show a coronal
(A), a sagittal view (B) and the result of the navigator (C).
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perfusion CMR (CMR-Perf).
Methods
Study population
From April 2010 until the end of April 2011, a total of 169
consecutive patients scheduled for XA were prospectively
recruited. Exclusion criteria were described before.5 Pa-
tients with coronary stents were included, but segments
containing stents were excluded from analysis (22 stents in
13 pts). The study protocol was approved by the local
ethics committee. All patients gave written informed
consent for the examinations and for anonymized statistical
data analysis.
Patient preparation
A β-blocker (metoprolol tartrate 50 mg) was given in cases of
a heart rate N75 beat/min before MRCA. Mild sedation with 1
and 2 mg IV midazolam (Dormicum, Hoffmann-La Roche,
Germany) was offered in case of anxiety or claustrophobia.
CMR acquisition techniques
All patients were examined in supine position in a whole-body
1.5-T scanner (Signa HDxt, GE Medical Systems, Milwaukee,
WI), equipped with EchoSpeed gradients, and a dedicated 8-
element phased-array cardiac coil. All examinations were carried
out by experienced technicians and supervised by a trained and
experienced physician.
For coronary artery imaging, a whole heart 3D navigator
gated multislab SSFP sequence (3D HEART, based on 3D
FatSat FIESTA; GE Healthcare, Milwaukee, WI) was
employed. It is designed for free-breathing MRCA, using a
navigator echo pulse that detects motion of the diaphragm.
Its multi-slab acquisition minimizes the effect of respiratory
drift and heart rate variability on image quality. The
navigator has been optimized to improve robustness, andincludes a slice-tracking feature (the slab position and in-
plane positions are shifted according to the detected
diaphragm position) to improve motion suppression and
increase scan efficiency (Figure 1). The R-wave acquired
from a 3-lead vector electrocardiogram was used to trigger
the data acquisition. For optimization of image quality a T2
preparation stage to reduce the myocardium signal, as well
as Kaiser-ramp steady state preparation and gradient spoiling
have been added. To ensure visualization of the most cranial
and caudal dimension of the coronary system, the built-in
multi-slab localizer was used, providing a sagittal overview.
A sufficient number of axial slices (20-30 per slab, 3-4 slabs,
resulting in a total of 80 to 120 slices, 2 mm thickness with
1 mm overlap) were then obtained to cover the whole
heart. Effective spatial resolution was 1.0 × 1.0 × 1.0 mm,
echo time, repetition time and flip angle were set to 2.3
milliseconds, 4.6 milliseconds and 90°, respectively. Tempo-
ral window to obtain the data was 245 milliseconds; 57
lines of data were collected during one heartbeat (mean
count). Data acquisition was stopped after 20 minutes if
navigator efficiency was too low or image quality in the first
slabs was non-diagnostic.
A combined protocol15 with MRCA and CMR-Perf was
performed in 59 of 96 patients (Figure 2). For CMR-Perf,
adenosine was infused intravenously at 140 μg/kg per minute
for 3 minutes. During the infusion, the setup of 3 short-axis
slices was planned, and the RR trigger was adjusted to the
heart rate after 2 min of infusion. During breath hold,
gadodiamid (Omniscan; GE Healthcare) was injected (0.1
mmol/kg body weight at a flow rate of 5 mL/s), and first-pass
perfusion images were acquired every heart beat using a
hybrid gradient echo/echo-planar pulse sequence (echo time
1.3 milliseconds, flip angle 25°, preparation pulse 90°, slice
thickness 10 mm, field of view 36 × 37cm, matrix 128 × 96).
Ten minutes after stress test, rest perfusion in same
orientations was performed using a second bolus of 0.1
mmol/kg body weight contrast agent. Ten minutes after the
second bolus, late gadolinium enhancement images (LGE)
Figure 2
CMR protocol—sequence of combined CMR protocol for performing MRCA and CMR-Perf in one session.
Figure 3
New algorithm for combination of CMR-Perf and MRCA.
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fast-gradient echo-pulse sequence.16
Image analysis and definitions
MRCA images were transferred to an external workstation (GE
Healthcare), patient information was removed, and all images
were assessed by 2 experienced readers who were blinded to the
patient information. If consensus could not be achieved, a third
opinion was included. Axial source images, curved reformations,
and thin-slab maximum intensity projection images were assessed
on a per-segment basis. The MR image quality was graded on a 4-
point scale: 1 = non-assessable with severe image artifacts, poorvessel contrast; 2 = assessable with moderate image artifacts, fair
vessel contrast; 3 = assessable with minor artefacts, good vessel
contrast; and 4 = assessable with no apparent artifacts, excellent
vessel contrast. American Heart Association (AHA) segments 1, 2,
3, 5, 6, 8, 11, and 13 were defined as suitable for percutaneous
coronary intervention (PCI).17 The volume rendering reconstruc-
tions of the coronary arteries were done with cvi42 (Circle
Cardiovascular Imaging Inc, Calgary, Canada).
Interpretation algorithms
First pass perfusion was assessed by visual comparison of
stress und rest with integration of LGE images.3 CMR-Perf was
Figure 4
Trial profile—patient inclusion, exclusion, and patients who were not successfully scanned.
1002 Heer et al
American Heart Journal
December 2013graded with scores 0 (normal), 1 (probably normal), 2 (probably
abnormal), or 3 (abnormal).6 A perfusion deficit was regarded
relevant if affecting at least two neighboring myocardial
segments and persisting for more than 5 heartbeats after
maximal signal intensity in the left ventricular cavity. LGE
images were analyzed visually and bright segments from
subendocardial to epicardial were classified as relevant fibrotic
tissue due to myocardial infarction. CMR-Perf was classified
positive when any post-ischemic scar was detected and/or if
perfusion deficit was probably abnormal or abnormal according
to the algorithm proposed by Klem et al.3
For the “CE-MARC” algorithmwe used information of CMR-Perf
(assessed by visual comparison of stress and rest CMR perfusion
scans, 16 segments of the 17 segment AHA/ACC model,
excluding the apical cap segment with scores of 0 (normal), 1
(equivocal), 2 (subendocardial ischemia/moderately reduced) or
3 (transmural ischemia/severely reduced), LGE, wall motion
abnormality and MRCA. If any component was positive, the
overall CMR result was judged positive; if all components were
negative, the CMR overall result was judged negative.15,18
A novel algorithm was used to combine the results of MRCA
and CMR-Perf. If there was no perfusion deficit in CMR-Perf, itwas classified negative, and if there was severe perfusion deficit,
it was classified positive. In cases of probably normal or
probably abnormal perfusion deficits the results of MRCA were
added. If MRCA revealed a stenosis ≥50% in any coronary
segment in these cases, the CMR was classified positive.
Otherwise (MRCA b50% stenosis and probably normal/abnor-
mal perfusion deficit), it was classified negative CMR (Figure 3).
Invasive coronary angiography
All patients underwent XA within 72 hours after or before
CMR examination. XA was carried out in accordance with the
guidelines of the ACC as previously described.5 Stenoses were
quantitatively evaluated for segments with a reference diameter
of 1.5 mm or more. Significant CAD was defined as luminal
narrowing of ≥50% in XA. Segments distal to complete
occlusions were excluded for analysis. The CMR physician
was blinded to the result of XA.
Statistical analysis
Categorical variables are presented as percentage of inci-
dence. Association between groups was assessed by means of
Table I. Characteristics of the study population
Characteristics
All patients with successful
MRCA (n = 96)
Combined protocol MRCA
and CMR-Perf (n = 59)
MRCA without
CMR-Perf (n = 37) P⁎
Age, yrs 59.7 ± 13 63.3 ± 9.9 53.9 ± 15.4 .005
Sex, male/female 59 (61%)/37 (39%) 36 (61%)/23 (39.2%) 23 (62%) /14 (38%)
Body mass index (kg/m2), 25.9 ± 3.8 25.7 ± 3.4 26.2 ±4.7 .9
Hypertension 47 (49%) 37 (63%) 10 (27%) .001
Diabetes mellitus 9 (9%) 6 (10.2%) 3 (8%) .8
Hypercholesterolemia 29 (30%) 21 (35.6%) 8 (22%) .2
Current of prior cigarette smoking 25 (26%) 13 (22.0%) 12 (32%) .2
Prior myocardial infarction 12 (12.5%) 10 (17.0%) 2 (5%) .2
Family history of CAD 25 (25%) 13 (22.0%) 11 (30%) .3
Creatinine, mg/dL 0.8 ± 0.2 0.8 ± 0.2 0.8 ± 0.2 .8
Cholesterol, mg/dL 194 ± 40 196 ± 39 190 ± 43 .4
Relevant CAD in CA (stenosis N50%) 31 (32.3%) 23 (39.0%) 8 (21.6%) .01
Data are expressed as mean ± SD or n (%).
⁎Comparing pts with and without CMR-Perf.
Table II. CMR parameters
Characteristics
Patients with successful
MRCA (n = 96)
Combined protocol MRCA
and CMR-Perf (n = 59)
MRCA without
CMR-Perf (n = 37) P⁎
Duration of MRCA sequence (min), 14.3 ± 6.2 14.3 ± 4.5 14.4 ± 8.4 .4
Duration of complete exam (min), 44.7 ± 8.7 43.6 ± 9.1 46.5 ± 7.7 .06
Type of exam
MRCA only (n) 9 (9%) 0 9
MRCA and CMR-Perf (n) 59 (61%) 59 0
MRCA and viability (n) 8 (8%) 0 8
MRCA and myocarditis (n) 23 (24%) 0 23
Other (n) 1 (1%) 0 1
Breathing regularly (n) 80 (83%) 49 (71%) 31 (84%) .9
Pulse regularly (n) 91 (95%) 56 (95%) 35 (95%) .9
β-Blocker given (n) 20 (21%) 11 (19%) 9 (24%) .5
Heart rate (beat/min) 61.6 ± 7.5 61.9 ± 7.7 61.1 ± 7.2 .8
Ejection fraction (%) 63.4 ± 10.6 62.6 ± 11.5 64.7 ± 9.0 .7
Navigator efficiency (%) 36.8 ± 9.8 38.2 ± 10.1 34.5 ± 9.0 .06
Data are expressed as mean ± SD or n (%).
⁎Comparing pts with and without CMR-Perf.
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SD. Shapiro-Wilk test was used to test for normal distribution.
Continuous variables were compared by t-test for unpaired
observations or Mann–Whitney U test, where appropriate. In all
cases, P b .05 was considered statistically significant.
The diagnostic performance of MRCA for the detection of
significant coronary artery stenosis (sensitivity, specificity,
positive predictive value [PPV], negative predictive value
[NPV], and accuracy with 95% confidence intervals) was
calculated on a per-segment, per-vessel, and per-patient basis
using XA as the reference standard. Non-assessable segments
were excluded from further analysis. McNemar test was used to
compare the diagnostic accuracy, sensitivity, and specificity of
techniques. PPV and NPV were compared with testing for
equality of binomial parameters. Analyses were performed with
commercially available statistic software (XLSTAT Version
2013.1.01, Addinsoft, Paris, France).No extramural funding was used to support this work.
The authors are solely responsible for the design and conduct
of this study, all study analyses, the drafting and editing of the
manuscript, and its final contents.
Results
Baseline characteristics
169 patients fulfilled the inclusion criteria. 25 of them
were excluded and in 48 of the remaining 144 patients
image quality was not sufficient for further MRCA analysis
(Figure 4). Overall, MRCA was successfully completed in
96 of 144 patients (67%). The characteristics of the study
population are summarized in Table I. Of 96 pts, 18
(18.8%) had 1-vessel CAD, 15 (15.6%) had 2-vessel CAD,
and 5 (5.2%) had 3-vessel CAD. As for pts with combined
Table III. Assessability and image quality of 96 patients with successful MRCA
Coronary segment
(AHA)
Assessable
segments
Image
quality
Reasons for low assessability⁎
Poor visualization Small caliber (b2 mm) Motion artifacts
Total⁎ 939/1226 (77%) 2.8 116 161 53
Segments suitable for PCI† 792/866 (92%) 3.0 16 7 14
RCA proximal (1) 94/94 (100%) 3.7 0 0 0
RCA middle (2) 92/94 (98%) 3.5 1 1 2
RCA distal (3) 79/94 (84%) 2.8 7 2 8
RCA PDA/PL (4) 32/94 (34%) 1.6 25 50 7
LM (5) 96/96 (100%) 3.7 0 0 0
LAD proximal (6) 90/90 (100%) 3.7 0 0 0
LAD middle (7) 91/92 (99%) 3.3 0 0 0
LAD distal (8) 78/96 (81%) 2.6 15 5 7
LAD diagonal (9,10) 42/96 (44%) 1.8 21 4 4
LCX proximal (11) 93/94 (99%) 3.3 0 1 1
LCX marginal (12) 35/96 (36%) 1.5 27 48 10
LCX middle (13) 83/94 (88%) 3.0 6 3 7
LCX distal (14,15) 45/96 (47%) 1.9 26 21 8
LM, Left main coronary artery.
⁎More than one answer was possible, poor visualization and motion artifacts, n = 9, small caliber and motion artifact, n = 7, poor visualization and small caliber, n = 33.
† Poor visualization and motion artifacts, n = 7, small caliber and motion artifact, n = 2, poor visualization and small caliber, n = 5.
Figure 5
MRCA of a 34-year-old man—MRCA of RCA—volume rendering.
Red arrows show that even right ventricular branches of RCA can be
depicted with excellent image quality. No relevant CAD.
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pts (15.3%) had CAD-1, 7/59 pts (11.9%) had CAD-2, and
7/59 pts (11.9%) had CAD-3. In 19/59 (32.2%) LGE was
present. Details to acquisition time and other CMR
parameters are given in Table II.
Image quality and assessability of whole heart MRCA
MRCA assessability and image quality are summarized
in Table III. There was a high assessability of left main
coronary artery, of proximal and medial left anterior
descending coronary artery (LAD) and RCA, and of the
proximal left circumflex coronary artery (LCX). Assessa-
bility was intermediate in distal RCA, distal LAD, and
medial LCX. There was low assessability of diagonal
branches of LAD, marginal branches and posterolateral
branches of LCX, and distal branches of RCA. In most of
these cases vessels were not visible due to their small
caliber (b2 mm). A typical MRCA example is depicted in
Figure 5.
Diagnostic performance of MRCA compared with XA
Sensitivity, specificity, and accuracy of 1.5-T whole-
heart MRCA are given in Table IV for all segments, for
segments which are suitable for PCI,17 on a per-vessel and
on a per-patient analysis. Examples for correlation of
MRCA and XA are given in Figure 6.
Combination of MRCA with CMR-Perf
The diagnostic performance for the combination of
MRCA and CMR-Perf compared to MRCA and CMR-Perf
was assessed in 59 patients. Results are given in Table V
(per patient analysis). Compared to the CMR-Perf
algorithm proposed by Klem et al,3 the novel algorithmfurther enhances specificity without worsening sensitiv-
ity (clinical example is given in Figure 7). Overall
accuracy is improving from 78.0% to 91.5%. Receiver
operating curve (ROC) analysis shows a trend for better
performance of the new algorithm: area under the curve
Table IV. Diagnostic performance of MRCA⁎
All assessable segments
n = 576
Segments suitable for PCI19
n = 437
Per vessel analysis
n = 232
Per patient analysis
n = 59
Accuracy 91.7% (528/576)
[89-94]
90.6% (396/437)
[88-93]
86.2% (200/232)
[82-91]
83.1% (49/59)
[74-93]
Sensitivity 88.9% (56/63)
[78-95]
89.8% (44/49)
[78-96]
88.1% (37/42)
[74-95]
86.7 (26/30)
[70-95]
Specificity 92.0% (41/513)
[89-94]
90.7% (352/388)
[87-93]
85.8% (163/190)
[80-90]
79.3% (23/29)
[61-90]
PPV 57.7% (56/97)
[48-68]
55.0% (44/80)
[44-66]
57.8% (37/64)
[46-70]
81.3% (26/32)
[68-95]
NPV 98.5% (472/479)
[98-100]
98.6% (352/357)
[97-100]
97.0% (163/168)
[95-100]
85.2% (23/27)
[68-96]
Values are shown as percentages. Data are % (raw data) [95% CI].
CI, Confidence interval; NPV, negative predictive value.
⁎ Fifty-nine pts with combined protocol MRCA and CMR-Perf.
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algorithm, AUC 0.80 (95% CI, 0.47-1.0), P = .06 (Figure 8).
The results of comparison of the different algorithms are
given in Table V.Discussion
Main finding of the present study is that non-contrast
enhanced whole-heart MRCA at 1.5-T allows for accurate
detection of relevant CAD with high sensitivity and
specificity in patients with regular breathing pattern.
Although performance of MRCA alone is inferior to that
reported for CMR-Perf,5,6,16,19 we could prove that
adding the result of MRCA to “low confidence” or
doubtful CMR-Perf results is feasible with an increase in
specificity without worsening CMR-Perf’s proven high
sensitivity. Overall, we could show that the combination
of MRCA and CMR-Perf has a high diagnostic accuracy.
In patients with successful MRCA, assessability of
coronary arteries was excellent in LM artery, in proximal
and middle segments of LAD, LCX and RCA, and good in
distal RCA and LAD. This is comparable to recent studies
20 and outperforms older reports.21 Our results were
unsatisfactory only in minor side branches.22 However,
CAD of distal side branches with sparing the proximal
and middle parts is rare, so that missing very distal
branches of coronary arteries by MRCAmight be of minor
clinical relevance. This is supported by a large study of
Kelle et al where in a total of 92,333 coronary stenoses
less than 5% of PCI were performed in distal coronary
segments.17
MRCA alone was able to reliably rule out significant
CAD with high negative predictive values. Similar to
previous studies21 PPVs were low. This may be due to an
overestimation of stenosis in cases of limited image
quality, especially in minor side branches with diameters
between 2 and 2.5 mm, causing false-positive results.
Although there have been ongoing efforts to enhance
performance of MRCA over the last decade,9-11,20,23-27MRCA is still limited by lower assessability of coronary
segments compared to CCTA of the latest generation.
Previous studies have shown superiority of CCTA.28
However, despite a trend toward higher diagnostic
performance of CCTA, a recent direct comparison of
MRCA at 3.0-T (32-element coils) and 64-slice CCTA
similarly indentified CAD.14
Our results at 1.5 T are comparable with the results of a
recent MRCA study at 3.0 T which was done in a single
center study in 69 patients. Apart from a slightly
prolonged examination time (+5 min) MRCA at 1.5-T
was not inferior to MRCA at 3.0 T.12 The main advantage
of MRCA at 1.5 T is the much broader availability in
clinical practice. In the most recently published Euro-
CMR registry 93.6% of all examinations (n = 25,899/
27,781) were done at 1.5 T.7 In addition, MRCA at 1.5-T
does not require Gadolinium-contrast which is required
for MRCA at 3.0 T.
Main reasons for impaired image quality are irregular
breathing patterns and severe arrhythmia. In one
approach, Ishida et al found that an abdominal belt
increased scan efficiency.29 Our study supports the
urgent need for further improvements in breathing
correction algorithms to enable a widespread use of
MRCA in clinical practice.
Main focus of our study was the assessment of a
combined MRCA and CMR-Perf protocol. In the past
years, several attempts were not successful to enhance
CMR-Perf results by adding the results of MRCA.18
Recently, the large CE-MARC trial showed CMR’s high
diagnostic accuracy in CAD and CMR's superiority over
single photon emission computed tomography but failed
to show an incremental value of MRCA.15 In this study
the overall CMR result was judged positive if any CMR
component was positive. To obviate the above-men-
tioned trend of MRCA to overestimate the grade of
stenoses, we applied a more differentiated algorithm. We
restricted MRCA integration to moderate perfusion
deficits which in our experience carry most of the
Figure 6
Correlation of MRCA and XA.A, A 71-year-old woman—volume rendering, LAD with 60% to 70% stenosis (white arrow). B, Corresponding XA of
LCA. C, A 73-year-old man—sliding thin-slab maximum intensity projection, 75% to 80% stenosis of RCA (broad arrow). The 50% to 60% stenosis
can also be seen (fine arrow). D, Corresponding XA of RCA.
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confidence results”). These can be real CAD-caused
ischemia, subendocardial ischemia in microvascular
disease (eg, small vessel disease19 in hypertensive heart
disease), small caliber coronary arteries,22 or these can be
artifacts (dark rim artifact, susceptibility artifacts, chem-
ical shift artifacts, partial volume artifacts, motion
artifacts).23 In these cases, we hypothesized that a more
elaborate algorithm which includes the direct visualiza-
tion of coronaries might reduce the false-positive
interpretation. MRCA at 1.5 T is independent of
gadolinium-induced artifacts and, thus, has the potential
to correct for these limitations of CMR-Perf. Our results
suggest an enhancement of diagnostic performance with
the combination of MRCA with CMR-Perf according tothe proposed algorithm, particularly by an increase in
specificity without worsening sensitivity. In conclusion,
we propose a more widespread use of CMR/MRCA in
clinical practice. MRCA has the fundamental advantage
that neither potentially nephrotoxic contrast agents nor
ionizing radiation are necessary.
The present study has several limitations. We present a
single-center study in a high volume (N1200 CMR
examinations/year) CMR center. Extrapolation to low
volume centers should be made with caution. All patients
were white northern Europeans who had not had
previous coronary artery bypass graft. Results might
differ in other populations. In our study we combined a
morphological test (MRCA) with a functional test (CMR-
Perf) and compared the result with XA as the currently
Table V. Performance of different algorithms to combine CMR-Perf, LGE and MRCA
CMR-Perf and LGE, no MRCA
(Klem) n = 59 pts
CMR-Perf, LGE with MRCA
(CE-MARC) n = 59 pts
CMR-Perf, LGE with MRCA
(novel algorithm) n = 59 pts
Accuracy 78.0% (46/59)
[67-89]
71.2% (42/59)
[60-83]
91.5% (54/59)⁎
[84-99]
Sensitivity 91.3% (21/23)
[72-99]
95.7% (22/23)
[77-100]
95.7% (22/23)†
[77-100]
Specificity 69.4% (25/36)
[67-93]
55.6% (20/36)
[40-70]
88.9% (32/36)‡
[74-96]
PPV 65.6% (21/32)
[49-82]
57.9% (22/38)
[42-74]
84.6% (22/26)§
[71-99]
NPV 92.6% (25/27)
[83-100]
95.2% (20/21)
[86-100]
97.0% (32/33)‖
[91-100]
Values are shown as percentages. Data are % (raw data) [95% confidence interval].
⁎Novel algorithm versus Klem, P = .07; versus CE-MARC, P b .01.
†Novel algorithm versus Klem, P = .32; versus CE-MARC, P = 1.0.
‡Novel algorithm versus Klem, P = .008; versus CE-MARC, P = .001.
§Novel algorithm versus Klem, P = .08; versus CE-MARC, P = .01.
‖Novel algorithm versus Klem, P = .56; versus CE-MARC, P = .74.
Figure 7
A and B, Clinical example for improved specificity by the new MRCA algorithm—Stress and rest perfusion CMR of a 72-year old woman with
moderate inducible ischemia (black arrows). C, Corresponding LGE shows preserved vitality. D-G, MRCA images of LAD (yellow arrow), RCA
(green arrow) and LCX (red arrow), showing no CAD N50%.H and I, Corresponding XA of LM, LCA and RCA without CAD. In summary perfusion
CMR is false positive; new algorithm including MRCA is true negative.
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Figure 8
ROC-Curves of 1.5-T whole-heart MRCA for detecting significant
CAD—comparison of the different algorithms for combination of
MRCA and CMR-Perf with MRCA alone. ROC analysis shows trend
for better performance of the new algorithm, AUC, 0.94 (95% CI,
0.82-0.99), compared to the former algorithm, AUC, 0.85 (95% CI,
0.71-0.94), P = .05.
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test results if lesions were judged relevant in
angiography, but stenoses were not hemodynamic
relevant if assessed by CMR-Perf. Fractional flow
reserve was not used in this study. Segments contain-
ing stents which could potentially be clinical relevant
were excluded from further analysis. The study was
underpowered to prove superiority of the new CMR
algorithm in ROC analysis. Therefore, our promising
results are hypothesis generating and have to be
confirmed in a larger trial.
Conclusion
In patients with a regular breathing pattern, non–
contrast-enhanced, whole-heart MRCA at 1.5 T allows
for detection of relevant coronary stenoses in coronary
segments suitable for PCI in clinical practice with high
sensitivity and specificity. We could show that it is
possible to combine CMR-Perf and MRCA in one
comprehensive examination with an increase in
specificity without worsening sensitivity. The major
challenge for the future will be to overcome the
current limitation caused by respiration-induced mo-
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